Drug Repurposing
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study (NCT07324473) | First Affiliated Hospital of Chongqing Medical University | 2026-01-01 |
Track Drug Repurposing automatically
Every clearance here is in the API, with alerts when new ones post.